PROTEIN-ASSOCIATED DNA BREAKS AS INDICATOR OF TOPOISOMERASE INHIBITION
PROTEIN-ASSOCIATED DNA BREAKS AS INDICATOR OF TOPOISOMERASE INHIBITION
批准号:
3916548
负责人:
Y POMMIER
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
DNA binding protein DNA repair DNA topoisomerases acridines antineoplastics breast neoplasms camptothecin doxorubicin drug adverse effect drug metabolism drug resistance enzyme inhibitors enzyme mechanism etoposide genetic transcription molecular oncology neoplasm /cancer chemotherapy neoplastic cell neoplastic cell culture for noncancer research podophyllin radiation carcinogenesis
中文摘要
DNA拓扑异构酶已被确定为癌症的主要靶标
化疗 两种类型的拓扑异构酶已被分离,
真核细胞核 拓扑异构酶1和II都使DNA松弛
在DNA复制中起着至关重要的作用,
转录。 然而,拓扑异构酶II是唯一能够
将DNA环锚在核基质上,
复制DNA圈 两个家族的抗癌药物抑制
拓扑异构酶II:DNA嵌入剂,如安吖啶(m-AMSA),
阿霉素和椭圆藤碱衍生物,和
去甲基表鬼臼毒素,如依托泊苷(VP-16)和
替尼泊苷(VM-26)。 药物诱导的拓扑异构酶II抑制
导致蛋白质相关DNA断裂的形成,
可通过碱性洗脱来检测。 我们现在已经证明,
特异性拓扑异构酶I抑制剂,喜树碱还产生
蛋白质相关的DNA断裂。 我们最近发现
拓扑异构酶抑制剂诱导的断裂与
强和弱可逆的DNA合成抑制,
aphidicolin防止拓扑异构酶抑制剂的细胞毒性
表明药物诱导的拓扑异构酶复合物可以发挥其
通过产生稳定的拓扑异构酶-DNA复合物的细胞毒作用
这会破坏DNA复制复合体的稳定性 最后我们
已经发现一种人类乳腺癌细胞系(MCF-7)耐药,
具有拓扑异构酶11修饰,
与药物摄取减少通常遇到的,
多效性抗性细胞系。
英文摘要
DNA topoisomerases have been identified as major targets for cancer
chemotherapy. Two types of topoisomerases have been isolated from
eukaryotic cell nuclei. Both topoisomerases 1 & II relax DNA
supercoiling and play a crucial role in DNA replication and
transcription. However, topoisomerase II is the only enzyme able
to anchor DNA loops to the nuclear matrix and to decatenate newly
replicated DNA circles. Two families of anticancer drugs inhibit
topoisomerase II: DNA intercalators, such as amsacrine (m-AMSA),
adriamycin and ellipticine derivatives, and
demethylepipodophyllotoxins, such as etoposide (VP-16) and
teniposide (VM-26). Drug-induced topoisomerase II inhibition
results in the formation of protein-associated DNA breaks, which
can be detected by alkaline elution. We have shown now, that the
specific topoisomerase I inhibitor, camptothecin produces also
protein-associated DNA breaks. Our recent finding that the DNA
breaks induced by topoisomerase inhibitors are associated with
strong and poorly reversible DNA synthesis inhibition, and that
aphidicolin prevents the cytotoxicity of topoisomerase inhibitors
suggest that drug-induced topoisomerase complexes could exert their
cytotoxic action by producing stable topoisomerase-DNA complexes
which would destabilize DNA replication complexes. Finally, we
have found that a human breast cancer cell line (MCF-7) resistant
to adriamycin has topoisomerase 11 modifications, which are
associated with the drug uptake reduction usually encountered in
pleiotropic resistant cell lines.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PROTEIN-ASSOCIATED DNA BREAKS AS INDICATOR OF TOPOISOMERASE INHIBITION
-
批准号:3752315
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
TOPOISOMERASE II AS TARGET OF ACTION OF ANTICANCER DRUG
-
批准号:3939497
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
PHARMACOLOGY OF THE HIV VIRAL DNA
-
批准号:3838171
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
PROTEIN-ASSOCIATED DNA BREAKS AS INDICATOR OF TOPOISOMERASE INHIBITION
-
批准号:3853153
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
PHARMACOLOGY OF THE HIV VIRAL DNA AND RETROVIRAL INTEGRASES
-
批准号:2463724
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
DNA TOPOISOMERASES AS TARGET OF ACTION OF ANTICANCER DRUGS
-
批准号:2463710
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
DNA TOPOISOMERASES AS TARGET OF ACTION OF ANTICANCER DRUGS
-
批准号:3838030
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
DNA TOPOISOMERASES AS TARGET OF ACTION OF ANTICANCER DRUGS
-
批准号:3752316
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
PROTEIN-ASSOCIATED DNA BREAKS AS INDICATOR OF TOPOISOMERASE INHIBITION
-
批准号:3774547
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
PROTEIN-ASSOCIATED DNA BREAKS AS INDICATOR OF TOPOISOMERASE INHIBITION
-
批准号:2463709
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
PROTEIN-ASSOCIATED DNA BREAKS AS INDICATOR OF TOPOISOMERASE INHIBITION
-
批准号:3874383
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
STUDIES OF TOPOISOMERASE II AS TARGET OF ACTION OF ANTICANCER DRUG
-
批准号:3963209
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
PROTEIN-ASSOCIATED DNA STRAND BREAKS AS INDICATOR OF TOPOI
-
批准号:4692081
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
STUDIES OF TOPOISOMERASE II AS TARGET OF ACTION OF ANTICANCER DRUG
-
批准号:4692083
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
PHARMACOLOGY OF THE HIV VIRAL DNA AND RETROVIRAL INTEGRASES
-
批准号:6100896
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
DNA TOPOISOMERASES AS TARGET OF ACTION OF ANTICANCER DRUGS
-
批准号:3774548
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
PROTEIN-ASSOCIATED DNA BREAKS AS INDICATOR OF TOPOISOMERASE INHIBITION
-
批准号:6160983
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
DNA TOPOISOMERASES AS TARGET OF ACTION OF ANTICANCER DRUGS
-
批准号:3916549
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
DNA TOPOISOMERASES AS TARGET OF ACTION OF ANTICANCER DRUGS
-
批准号:5201240
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
PHARMACOLOGY OF THE HIV VIRAL DNA
-
批准号:5201355
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
海外基金